Open Chemistry,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Jan. 1, 2024
Abstract
Dengue
virus
(DENV)
infection
is
one
of
the
diseases
for
which
no
drug
available
treatment.
The
DENV
NS2B-NS3
protease
considered
to
be
prime
target
anti-dengue
development
because
its
importance
in
new
subunits
via
poly-protein
breakdown.
Pentacyclic
triterpenoids
(Lantadenes)
from
weed
Lantana
camara
L.
and
semi-synthetic
congeners
have
shown
a
wide
array
biological
activities
last
two
decades.
virtual
screening
strategy
was
used
on
library
78
natural
lantadenes
predict
potent
antagonists
enzyme
their
experimental
validation
by
vitro
assay
lead
molecules.
In
silico
analysis
triterpenoids,
molecules
(−10.60
−9.93
kcal/mol)
were
predicted
inhibitors
(viral)
when
compared
reference
ligand
1,8-dihydroxy-4,5-dinitroanthraquinone
(−5.377
kcal/mol).
At
same
time,
binding
affinity,
pharmacokinetic,
toxicity
profiling,
along
with
molecular
dynamics
simulations,
studied.
viral
inhibition
inferred
that
molecule
62
exhibited
60%
45%
reduction
titers
at
10
5
µM
concentrations,
respectively.
can
further
optimized
pharmacophore
has
potential
developed
as
drug-like
molecule.
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(12), P. 2056 - 2056
Published: Nov. 29, 2023
Cancer
is
one
of
the
most
serious
public
health
issues
worldwide,
demanding
ongoing
efforts
to
find
novel
therapeutic
agents
and
approaches.
Amid
growing
interest
in
oncological
applications
phytochemicals,
particularly
polyphenols,
resveratrol-a
naturally
occurring
polyphenolic
stilbene
derivative-has
emerged
as
a
candidate
interest.
This
review
analyzes
pleiotropic
anti-cancer
effects
resveratrol,
including
its
modulation
apoptotic
pathways,
cell
cycle
regulation,
inflammation,
angiogenesis,
metastasis,
interaction
with
cancer
stem
cells
tumor
microenvironment.
The
resveratrol
on
mitochondrial
functions,
which
are
crucial
development,
also
discussed.
Future
research
directions
identified,
elucidation
specific
molecular
targets,
facilitate
clinical
translation
prevention
therapy.
Cancer Immunology Immunotherapy,
Journal Year:
2025,
Volume and Issue:
74(3)
Published: Feb. 1, 2025
Imiquimod
(IMQ),
a
drug
from
aminoquinoline
group,
is
the
toll-like
receptor
7
(TLR7)
agonist.
It
acts
as
an
immunostimulant
and
radio-sensitizing
agent.
IMQ
stimulates
both
innate
adaptive
immune
response.
Despite
studies
conducted,
there
are
no
unambiguous
data
showing
how
affects
condition
of
tumor
blood
vessels.
Tumor
vasculature
plays
main
role
in
progression.
Formation
abnormal
vessels
increases
area
hypoxia
which
recruits
suppressor
cells,
blocks
infiltration
by
CD8+
T
lymphocytes,
inhibits
efficacy
chemoterapeutic
leads
to
cancer
relapse.
Normalization
type
therapy
targeted
at
Here,
we
demonstrated
that
50
µg
growth
melanoma
tumors
more
efficiently,
compared
other
tested
doses
control
group.
Dose
escalation
did
not
improve
therapeutic
antitumor
potential
TLR7
A
dose
most
effectively
reduced
vessel
density.
normalized
structurally
(by
reducing
tortuosity
increasing
pericyte
coverage)
functionally
improving
perfusion)
dose-dependent
manner.
Hypoxia
regions
treated
mice
were
significantly
after
administration.
had
also
greatest
impact
on
changes
tumor-infiltrating
lymphocytes
levels.
agonist
inhibited
angiogenesis
mice.
Functional
vascular
normalization
effectiveness
low
doxorubicin.
Higher
showed
worse
effects
than
lower
including
decreased
perfusion,
increased
immunosuppression.
This
knowledge
may
help
optimize
combination
selected
with
e.g.
chemotherapy
or
radiotherapy
elicit
synergistic
effect
treatment.
To
conclude,
outline
repurposing
normalizing
Our
research
results
contribute
expanding
indications
for
use
anticancer
future.
iScience,
Journal Year:
2023,
Volume and Issue:
26(8), P. 107408 - 107408
Published: July 17, 2023
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
an
aggressive
cancer
with
high
metastasis
and
therapeutic
resistance.
Activating
transcription
factor
4
(ATF4),
a
master
regulator
of
cellular
stress,
exploited
by
cells
to
survive.
Prior
research
data
reported
provide
evidence
that
ATF4
expression
correlates
worse
overall
survival
in
PDAC.
Tomatidine,
natural
steroidal
alkaloid,
associated
inhibition
signaling
multiple
diseases.
Here,
we
discovered
vitro
vivo
tomatidine
treatment
PDAC
inhibits
tumor
growth.
Tomatidine
inhibited
nuclear
translocation
reduced
the
transcriptional
binding
downstream
promoters.
enhanced
gemcitabine
chemosensitivity
3D
ECM-hydrogels
vivo.
was
induction
ferroptosis
validated
increased
lipid
peroxidation,
mitochondrial
biogenesis,
decreased
GPX4
cells.
This
study
highlights
possible
approach
utilizing
plant-derived
metabolite,
tomatidine,
target
activity
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(7), P. 775 - 775
Published: June 27, 2024
Rheumatoid
arthritis
(RA)
is
a
persistent
autoimmune
disorder
that
characterized
by
joint
inflammation,
discomfort,
and
impairment.
Despite
the
existence
of
several
therapeutic
approaches,
their
effectiveness
often
restricted
may
be
linked
to
unfavorable
side
effects.
Consequently,
there
has
been
growing
interest
in
investigating
naturally
derived
compounds
as
plausible
agents
for
RA
disease.
The
objective
this
review
summarize
existing
preclinical
clinical
evidence
regarding
efficacy
extracted
plant
extracts
treatment
RA,
focusing
on
anti-inflammatory,
anti-oxidative,
immunomodulatory
properties.
Some
problems
with
using
natural
chemicals
are
uneven
quality
commercially
available
preparations
poor
bioavailability
these
compounds.
Future
investigations
should
focus
improving
formulations,
conducting
thorough
trials,
exploring
different
techniques
fully
utilize
intrinsic
potential
treating
RA.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(6), P. 701 - 701
Published: May 28, 2024
Neurodegenerative
diseases
(Alzheimer’s
disease,
Parkinson’s
Huntington’s
and
others)
cancer,
seemingly
disparate
in
their
etiology
manifestation,
exhibit
intriguing
associations
certain
cellular
molecular
processes.
Both
cancer
neurodegenerative
involve
the
deregulation
of
processes
such
as
apoptosis,
proliferation,
DNA
repair
pose
a
significant
global
health
challenge.
Afzelin
(kaempferol
3-O-rhamnoside)
is
flavonoid
compound
abundant
various
plant
sources.
exhibits
diverse
range
biological
activities,
offering
promising
prospects
for
treatment
hallmarked
by
oxidative
stress
cell
death
pathways.
Its
protective
potential
against
also
alleviating
side
effects
chemotherapy.
This
review
explores
therapeutic
implications
afzelin,
including
its
capacity
to
mitigate
stress,
modulate
inflammation,
promote
regeneration
diseases.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(39)
Published: Aug. 19, 2024
Abstract
Pyroptosis
possesses
potent
antitumor
immune
activity,
making
pyroptosis
inducer
development
a
promising
direction
for
tumor
immunotherapy.
Persistent
luminescence
nanoparticles
(PLNPs)
are
highly
sensitive
optical
probes
extensively
employed
in
diagnosis
and
therapy.
However,
based
on
PLNPs
has
not
been
reported
yet.
Herein,
polyethylene
glycol–poly
lactic
acid‐co‐glycolic
acid
(PEG–PLGA:
PP)
modified
biodegradable
CaS:Eu
2+
(CSE@PP)
synthesized
as
immunotherapy
the
first
time.
The
CSE@PP
biowindow
persistent
(PersL)
pH‐responsive
degradation
properties,
allowing
it
to
remain
stable
under
neutral
pH
but
degrade
when
exposed
weak
(pH
<
6.5).
During
within
tumor,
constantly
releases
H
2
S
Ca
while
its
PersL
gradually
fades
away.
Thus,
signal
can
self‐monitor
release.
Furthermore,
released
result
mitochondrial
dysfunction
inactivation
of
reactive
oxygen
species
scavenging
enzymes,
synergistic
facilitating
intracellular
oxidative
stress,
which
induces
caspase‐1/GSDM‐D
dependent
subsequent
responses.
In
word,
is
confirmed
that
release
pyroptosis‐mediated
Immunotherapy.
This
work
will
facilitate
biomedical
applications
inspire
pyroptosis‐induced
International Journal of Secondary Metabolite,
Journal Year:
2025,
Volume and Issue:
12(1), P. 1 - 15
Published: Jan. 19, 2025
Glioblastoma
is
one
of
the
most
common
and
destructive
types
tumors,
with
an
increasing
number
around
world.
Alpha-bisabolol
a
plant
secondary
metabolite
discovered
anticancer
activity,
which
can
also
be
considered
potential
treatment
for
glioblastoma.
In
silico
investigations
provide
adequate
information
understanding
roles
alpha-bisabolol
compounds
in
For
this
purpose,
computational
drug
design
procedures
were
applied
to
investigate
anti-glioblastoma
biotherapeutic
compounds.
study,
bcl-2
family
proteins'
inhibitory
activity
their
toxicity
properties
investigated
by
molecular
docking
studies.
Toxicity
evaluated
prediction
tools
as,
CarcinoPred
carcinogenicity
LAZAR
mutagenicity,
pkCSM,
SwissADME
absorption,
distribution,
metabolism,
excretion
(ADMET)
analysis
BOILED-Egg
model,
PASS
analyze
biological
functions
druggability,
DruLiTo
program
compute
likeness
property
QSAR
Toolbox
modeling.
The
results
reveal
oxide
B,
alpha
bisabolol
derivative,
glioblastoma
mechanisms
proteins,
being
non-toxic
non-mutagenic.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1376 - 1376
Published: Feb. 6, 2025
Cancer
is
a
multifaceted
disease
characterised
by
uncontrolled
cellular
proliferation
and
metastasis,
resulting
in
significant
global
mortality.
Current
therapeutic
strategies,
including
surgery,
chemotherapy,
radiation
therapy,
face
challenges
such
as
systemic
toxicity
tumour
resistance.
Recent
advancements
have
shifted
towards
targeted
therapies
that
act
selectively
on
molecular
structures
within
cancer
cells,
reducing
off-target
effects.
Mitochondria
emerged
pivotal
targets
this
approach,
given
their
roles
metabolic
reprogramming,
retrograde
signalling,
oxidative
stress,
all
of
which
drive
the
malignant
phenotype.
Targeting
mitochondria
offers
promising
strategy
to
address
these
mechanisms
at
origin.
Synthetic
derivatives
natural
compounds
hold
particular
promise
mitochondrial-targeted
therapies.
Innovations
drug
design,
use
conjugates
nanotechnology,
focus
optimizing
for
mitochondrial
specificity.
Such
enhance
efficacy
while
minimizing
toxicity,
presenting
step
forward
modern
anticancer
strategies.
Molecules,
Journal Year:
2025,
Volume and Issue:
30(4), P. 972 - 972
Published: Feb. 19, 2025
The
plant
kingdom
serves
as
a
valuable
resource
for
cancer
drug
development.
This
study
explored
the
antitumor
activity
of
different
sub-fractions
(hexane,
dichloromethane
and
methanol)
U.
gallii
(gorse)
methanol
extract
in
glioblastoma
(U-87MG
U-373MG)
neuroblastoma
(SH-SY5Y)
cell
lines,
along
with
their
phytochemical
profiles.
Cytotoxicity
was
evaluated
using
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide
(MTT)
lactate
dehydrogenase
(LDH)
assays,
cycle
arrest
apoptosis
were
assessed
through
flow
cytometry
by
measuring
reactive
oxygen
species
(ROS)
protein
expression
levels.
D7
D8
significantly
reduced
viability,
triggered
early
SH-SY5Y
U-87MG
cells
specifically
increased
ROS
levels
cells.
Western
blot
analyses
showed
that
p53,
caspase-3,
caspase-8
γH2AX
cells,
while
elevated
p53
caspase-3
both
lines.
In
U-373
markedly
inducing
necrosis.
Morphological
changes
indicative
also
observed
all
Bioinformatic
analysis
UHPLC-MS
GC-MS
data
tentatively
identified
20
metabolites
15
D8,
primarily
flavonoids.
HPLC-DAD
confirmed
isoprunetin
genistein
most
abundant
respectively,
isolated
NMR
spectroscopy.
Most
flavonoids
have
been
reported
agents,
suggesting
these
compounds
may
be
responsible
pharmacological
activity.